Updated:
NewOrigin Investments
NewOrigin Investments was founded by Ben Brandes, who previously led three investment funds and managed more than $1B in control-oriented private equity.
NewOrigin Investments
NewOrigin Investments was founded by Ben Brandes, who previously led three investment funds and managed more than $1B in control-oriented private equity. The firm targets founder-led, growth-stage companies in aging, healthcare, and financial wellness sectors, according to its website. The firm pursues buyout, growth equity, and secondary transactions across North America. Its primary sectors include digital health, healthcare services, and sports and wellness. NewOrigin provides capital for liquidity, organic growth, acquisitions, and buy-and-build strategies, positioning itself as hands-on partner rather than a passive investor. NewOrigin operates from Boston. The firm's structure integrates strategic guidance and operational support directly into its investment approach, though specific team size and additional office locations are not publicly disclosed. A structural differentiator is NewOrigin's exclusive focus on founder-led businesses in quality-of-life sectors—a narrow mandate that departs from generalist PE models. Brandes' background building private equity practices at CrossCountry Consulting, Accordion Partners, and Grant Thornton informs the firm's emphasis on in-the-trenches partnership with operators.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, United States
Principals
Ben Brandes
Founder
Sector focus
Frequently asked questions
Who makes investment decisions at NewOrigin?
Founder Ben Brandes leads investment decisions, drawing on more than 25 years of private equity and capital strategy experience. He previously ran three investment funds and built business development functions for PE practices at CrossCountry Consulting, Accordion Partners, and Grant Thornton.
What investment stages does NewOrigin target?
NewOrigin focuses on profitable, growth-stage companies that are already generating revenue. The firm provides capital for liquidity events, organic expansion, acquisitions, and buy-and-build strategies rather than early-stage venture funding.
Does NewOrigin invest as a passive LP or take control positions?
Brandes' background is in control-oriented private equity, and NewOrigin's stated model emphasizes hands-on partnership. The firm works alongside leadership teams to scale operations, suggesting active engagement rather than passive minority stakes.
Which sectors does NewOrigin explicitly avoid?
The firm has not published a negative sector list. Its stated focus is intentionally narrow: healthcare, aging, and financial wellness—sectors tied to quality-of-life outcomes. Companies outside those verticals are unlikely to fit its mandate.
How does NewOrigin source its deals?
Brandes' two-decade network built through investment banking, fund leadership, and PE practice development at professional services firms likely constitutes the primary origination channel. The firm does not publicly disclose a formal intermediary or broker program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: